+

CN1748499A - lung preservation solution - Google Patents

lung preservation solution Download PDF

Info

Publication number
CN1748499A
CN1748499A CN 200510104232 CN200510104232A CN1748499A CN 1748499 A CN1748499 A CN 1748499A CN 200510104232 CN200510104232 CN 200510104232 CN 200510104232 A CN200510104232 A CN 200510104232A CN 1748499 A CN1748499 A CN 1748499A
Authority
CN
China
Prior art keywords
organ
dextran
osmotic pressure
magnesium sulfate
ulinastatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510104232
Other languages
Chinese (zh)
Other versions
CN1307871C (en
Inventor
郭雷
段明科
李甦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shantou University Medical College
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2005101042322A priority Critical patent/CN1307871C/en
Publication of CN1748499A publication Critical patent/CN1748499A/en
Application granted granted Critical
Publication of CN1307871C publication Critical patent/CN1307871C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The lung preserving liquid as a kind of fresh live organ preserving matter contains in each liter sodium chloride 0.6-1.0g, potassium chloride 0.02-0.04g, magnesium sulfate 7.0-7.6g, sodium bicarbonate 0.6-1.0g, dextran-40 40-60g and Ulinastatin 25,000-50,000 U, and has osmotic pressure of 300-350mosm/L. The present invention is developed on modern organ maintaining technology, combines antioxidant effect, special permeating effect and cell exchange promoting mechanism, and applies Ulinastatin in organ preservation, and thus has less damage of preserved organ, prolonged organ maintaining period, and improved organ transplanting effect.

Description

肺保存液lung preservation solution

本发明为一种肺保存液,属于一种鲜活器官保存物质。The invention relates to a lung preservation solution, which belongs to a fresh and living organ preservation substance.

目前进行肺保存的物质一般有细胞内液型保存液和细胞外液型保存液,前者以Euro-collins液(EC液)和University of wisconsin(U液)为主,后者以低钾右旋糖酐液为主。前者对肺的保存效果较差,一般为4~6小时,而且,这两种保存液均为高钾溶液,对肺的损害较大。后者也未见保存时间超过6小时的报道。At present, the materials for lung preservation generally include intracellular liquid type preservation liquid and extracellular liquid type preservation liquid. The former is mainly composed of Euro-collins liquid (EC liquid) and University of wisconsin (U liquid), while the latter is mainly composed of low potassium dextran liquid. Mainly. The preservation effect of the former on the lungs is poor, generally 4 to 6 hours, and both of these two preservation solutions are high-potassium solutions, which will cause greater damage to the lungs. The latter also has no reports of preservation time exceeding 6 hours.

本发明的目的在于,公开一种保存效果好的肺保存液。The purpose of the present invention is to disclose a lung preservation solution with good preservation effect.

本发明是由氯化钠、氯化钾、硫酸镁、碳酸氢钠、右旋糖酐-40、渗透压与水混合而成,其中,每升中各成份的含量为:氯化钠:0.6~1.0g,氯化钾0.02~0.04g,硫酸镁7.0~7.6g,碳酸氢钠0.6~1.0g,右旋糖酐-40:40~60g,乌司他丁:25,000~50,000u/kg;其渗透压的数值范围为300~350mosm/l。本发明中含有乌司他丁,它能够起到抑制组织细胞代谢的作用,使被保存的器官在10℃左右的保存温度下降低代谢酶活性,减少分解代谢,延长组织细胞生命,达到预期的保存器官功能的目的。它以现代器官保存技术理论为基础,结合抗氧化、特殊的渗透作用、细胞交换促进机制,将乌司他丁运用于器官保存方面,用于减少器官移植中的缺血再灌注损伤、延长器官移植的保存时间,减少保存期的损伤,降低移植后原发性无功能的发生率,减少保存损伤而导致的排斥反应,从而从总体上改善器官移植的近期和远期效果。它可以使实验动物离体移植器官的保存时间延长1倍。在具体生产时,组成本发明的各成份可采用以下具体数据:每升中各成份的含量为:氯化钠:0.8~0.9g,氯化钾0.02~0.04g,硫酸镁7.2~7.5g,碳酸氢钠0.8~0.9g,右旋糖酐-40:45~50g,乌司他丁30,000~40,000u/kg,渗透压的数值范围为310~330mosm/l。The present invention is formed by mixing sodium chloride, potassium chloride, magnesium sulfate, sodium bicarbonate, dextran-40, osmotic pressure and water, wherein, the content of each component in each liter is: sodium chloride: 0.6~1.0g , potassium chloride 0.02~0.04g, magnesium sulfate 7.0~7.6g, sodium bicarbonate 0.6~1.0g, dextran-40: 40~60g, ulinastatin: 25,000~50,000u/kg; the numerical range of its osmotic pressure 300-350 mosm/l. The present invention contains ulinastatin, which can inhibit the metabolism of tissue cells, reduce the activity of metabolic enzymes in the preserved organs at a storage temperature of about 10°C, reduce catabolism, prolong the life of tissue cells, and achieve the desired effect. The purpose of preserving organ function. It is based on the theory of modern organ preservation technology, combined with anti-oxidation, special osmotic effect, and cell exchange promotion mechanism. The storage time of transplantation can reduce the damage during the storage period, reduce the incidence of primary non-function after transplantation, and reduce the rejection caused by storage damage, so as to improve the short-term and long-term effects of organ transplantation as a whole. It can double the preservation time of the isolated transplanted organs of experimental animals. When concrete production, each composition of forming the present invention can adopt following specific data: the content of each composition in every liter is: sodium chloride: 0.8~0.9g, potassium chloride 0.02~0.04g, magnesium sulfate 7.2~7.5g, Sodium bicarbonate 0.8-0.9g, dextran-40: 45-50g, ulinastatin 30,000-40,000u/kg, osmotic pressure ranges from 310-330mosm/l.

具体实施方式Detailed ways

各实施例中每升溶液中各成份的含量如下:     参数     成份   实施例1   实施例2   实施例3   实施例4   实施例5   实施例6   实施例7   实施例8   实施例9     氯化钠(g)   0.6   0.65   0.7   0.75   0.8   0.85   0.9   0.95   1.0     氯化钾(g)   0.02   0.03   0.04   0.025   0.035   0.04   0.02   0.03   0.035     硫酸镁(g)   7.35   7.4   7.0   7.3   7.4   7.6   7.2   7.1   7.5     碳酸氢钠(g)   0.7   0.65   0.9   0.6   0.8   0.85   1.0   0.95   0.75     右旋糖酐-40(g)   45   53   50   47   40   43   60   55   57 渗透压(mosm/l)   310   345   320   315   330   335   340   325   350     乌司他丁(u/kg)   30000   48000   40000   25000   32000   37000   50000   42000   38000 The content of each composition in every liter of solution in each embodiment is as follows: parameter ingredients Example 1 Example 2 Example 3 Example 4 Example 5 Example 6 Example 7 Example 8 Example 9 Sodium chloride (g) 0.6 0.65 0.7 0.75 0.8 0.85 0.9 0.95 1.0 Potassium chloride (g) 0.02 0.03 0.04 0.025 0.035 0.04 0.02 0.03 0.035 Magnesium sulfate (g) 7.35 7.4 7.0 7.3 7.4 7.6 7.2 7.1 7.5 Sodium bicarbonate (g) 0.7 0.65 0.9 0.6 0.8 0.85 1.0 0.95 0.75 Dextran-40(g) 45 53 50 47 40 43 60 55 57 Osmotic pressure (mosm/l) 310 345 320 315 330 335 340 325 350 Ulinastatin (u/kg) 30000 48000 40000 25000 32000 37000 50000 42000 38000

上述各实施例中的成份在常温下混合制成本发明。按上述成份制成的本发明其渗透压参数不在要求范围之内时,按公知方法对其进行调整。The ingredients in the above-mentioned embodiments are mixed at normal temperature to make the present invention. When the osmotic pressure parameter of the present invention made by the above-mentioned ingredients is not within the required range, it can be adjusted by known methods.

Claims (3)

1, a kind of lung preserving liquid, it is characterized in that: it is to be mixed by sodium chloride, potassium chloride, magnesium sulfate, sodium bicarbonate, dextran-40, osmotic pressure and water, wherein, the content of each composition is in every liter: sodium chloride: 0.6~1.0g, potassium chloride: 0.02~0.04g, magnesium sulfate: 7.0~7.6g, sodium bicarbonate: 0.6~1.0g, dextran-40: 40~60g, UTI: 25,000~50,000u/kg; The number range of its osmotic pressure is 300~350mosm/l.
2, lung preserving liquid according to claim 1, it is characterized in that: the content of each composition is in every liter: sodium chloride: 0.8~0.9g, potassium chloride: 0.02~0.04g, magnesium sulfate: 7.2~7.5g, sodium bicarbonate: 0.8~0.9g, dextran-40: 45~50g, UTI 30,000~40,000u/kg; The number range of osmotic pressure is 310~330mosm/1.
3, lung preserving liquid according to claim 2, it is characterized in that: the content of each composition is sodium chloride: 0.8~0.9g in every liter, potassium chloride: 0.02~0.04g, magnesium sulfate: 7.2~7.5g, sodium bicarbonate: 0.8~0.9g, dextran-40: 45~50g, UTI 30,000~40,000u/kg, the number range of osmotic pressure is 310~330mosm/l.
CNB2005101042322A 2005-10-11 2005-10-11 Lung preserving liquid Expired - Fee Related CN1307871C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005101042322A CN1307871C (en) 2005-10-11 2005-10-11 Lung preserving liquid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005101042322A CN1307871C (en) 2005-10-11 2005-10-11 Lung preserving liquid

Publications (2)

Publication Number Publication Date
CN1748499A true CN1748499A (en) 2006-03-22
CN1307871C CN1307871C (en) 2007-04-04

Family

ID=36604302

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005101042322A Expired - Fee Related CN1307871C (en) 2005-10-11 2005-10-11 Lung preserving liquid

Country Status (1)

Country Link
CN (1) CN1307871C (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101803594A (en) * 2009-02-14 2010-08-18 青岛华仁药业股份有限公司 Organ preservation solution and preparation method thereof
CN103461322A (en) * 2012-06-07 2013-12-25 臻景生物技术(上海)有限公司 Preservation solution for freezing resuscitated cells
CN106342788A (en) * 2011-04-14 2017-01-25 特兰斯迈迪茨公司 Organ care solution for ex-vivo machine perfusion of donor lungs
CN112273373A (en) * 2020-10-29 2021-01-29 无锡市人民医院 Isolated lung mechanical perfusion liquid and preparation method and application thereof
CN113498777A (en) * 2021-07-26 2021-10-15 公卫复医(上海)生物科技有限公司 Emulsion type organ preservation solution and preparation method thereof

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101803594A (en) * 2009-02-14 2010-08-18 青岛华仁药业股份有限公司 Organ preservation solution and preparation method thereof
CN101803594B (en) * 2009-02-14 2013-07-31 青岛华仁药业股份有限公司 Organ preservation solution and preparation method thereof
CN106342788A (en) * 2011-04-14 2017-01-25 特兰斯迈迪茨公司 Organ care solution for ex-vivo machine perfusion of donor lungs
CN106342788B (en) * 2011-04-14 2020-03-17 特兰斯迈迪茨公司 Organ care solution for ex vivo machine perfusion of donor lungs
CN103461322A (en) * 2012-06-07 2013-12-25 臻景生物技术(上海)有限公司 Preservation solution for freezing resuscitated cells
CN103461322B (en) * 2012-06-07 2016-08-03 西比曼生物科技(上海)有限公司 The preservation liquid of the cell after cryopreservation resuscitation
CN112273373A (en) * 2020-10-29 2021-01-29 无锡市人民医院 Isolated lung mechanical perfusion liquid and preparation method and application thereof
CN112273373B (en) * 2020-10-29 2022-06-07 无锡市人民医院 Isolated lung mechanical perfusion liquid and preparation method and application thereof
CN113498777A (en) * 2021-07-26 2021-10-15 公卫复医(上海)生物科技有限公司 Emulsion type organ preservation solution and preparation method thereof

Also Published As

Publication number Publication date
CN1307871C (en) 2007-04-04

Similar Documents

Publication Publication Date Title
US8017311B2 (en) Method for treatment of cellular materials with sugars prior to preservation
CN101228898A (en) Composite preservative for prolonging storage time of loquat fruit and preparation method thereof
JP2010539107A5 (en)
CN104996396A (en) In-vitro liver perfusion preservation solution
CN102630829B (en) Athetis lepigone larva feed and preparation method thereof
CN1307871C (en) Lung preserving liquid
CN106538510A (en) The application of lycopene and sesamol compatibility in domestic animal semen cryopreservation agent
CN108424318A (en) A kind of raising crop resists ammonium gluconate preparation of salt stress ability and the preparation method and application thereof
CN102144665A (en) A silver-loaded nano-TiO2 antibacterial and fresh-keeping method for Nanfeng Tangerine
CN103734280A (en) Fructus momordicae preservative and application method thereof
CN103719264A (en) Mango water retention sterilization filming liquid and preparation method thereof
CN106172719A (en) A kind of snap bean antistaling agent
CN110754442A (en) Silkworm embryo low-temperature protection and seed-delay technology
CN108419723A (en) A kind of carbon dioxide narcosis method of seawater grouper
CN102626112B (en) A kind of composite anti-transpiration agent and its preparation method and application
JPH10229708A (en) Method for accelerating germination
CN109122663A (en) A kind of freeze-drying refrigeration for the very wide water flea resting egg in the long-term preservation Pacific Ocean
CN110178834A (en) A kind of grouper sperm cryopreservation method
CN107801764A (en) A kind of preservation method of program cooling krill
CN115918533A (en) A method for ultra-low temperature preservation of Guimu No. 1 Elephant Grass droplet vitrification method
Třeška et al. Can ischemia-reperfusion syndrome in transplanted kidneys procured from non–heart-beating donors be influenced by adding selenium into the reperfusion solution? an experimental study
Gudleifsson Metabolic and cellular impact of ice encasement on herbage plants
CN106342786A (en) Diluent for in-vitro low temperature preservation of boar semen and preparation method thereof
CN105248610A (en) Egg fresh-keeping agent
Sudomo et al. Water, energy, and food nexus with agroforestry system for sustainable development goals

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: MEDICAL COLLEGE OF SHANTOU UNIVERSITY

Free format text: FORMER NAME OR ADDRESS: GUO LEI

C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载